Francis Chi
Chief Executive Officer chez WALCOM GROUP LIMITED
Profil
Francis Chi is the founder of Obio Pharmaceutical Holdings Ltd.
He is currently the CEO, CFO & Executive Director at Walcom Group Ltd.
and the Director at Antiviral Technologies, Inc. Previously, he served as the Managing Director at Becoin Ltd.
and the Sales Manager at Listo Enterprises Co. Ltd.
Mr. Chi obtained his undergraduate degree from Seattle University in 1984.
Postes actifs de Francis Chi
Sociétés | Poste | Début |
---|---|---|
WALCOM GROUP LIMITED | Chief Executive Officer | 01/01/2004 |
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Director/Board Member | 05/04/2010 |
Obio Pharmaceutical Holdings Ltd.
Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | Founder | - |
Anciens postes connus de Francis Chi
Sociétés | Poste | Fin |
---|---|---|
Becoin Ltd. | Corporate Officer/Principal | 01/01/1990 |
Listo Enterprises Co. Ltd. | Sales & Marketing | 01/01/1986 |
Formation de Francis Chi
Seattle University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
Walcom Group Ltd.
Walcom Group Ltd. Pharmaceuticals: GenericHealth Technology Walcom Group Ltd. is a holding company, which engages in the research, development, commercialization, production and marketing of animal feed additive products. Its products include Porcinin Plus, Porcimax, Eggronin Plus, and Aquanin Plus. It operates through the following geographical segments: Hong Kong, China, Philippines, Thailand, Taiwan, Other Asia-Pacific Countries, Europe and the United Kingdom, America and Canada, and Others. The company was founded in 2004 and is headquartered in Shanghai, China. | Health Technology |
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Finance |
Obio Pharmaceutical Holdings Ltd.
Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | Health Technology |
Becoin Ltd. | |
Listo Enterprises Co. Ltd. |